Maintaining a high degree of cardiorespiratory fitness (CRF) appears to be one way to reach old age without developing ...

The findings sparked a debate about the merits of RCTs vs other study designs—one surgeon urged others to “read a textbook.” ...

In patients who require a valve-in-valve (ViV) transcatheter procedure for a failed aortic bioprosthesis, the choice of ...

The findings underscore that pregnancy is “a crucial window of opportunity to optimize cardiovascular health,” researchers ...

With a mix of causes and comorbidities, type 2 MI patients do better than type 1 early on, then face worse long-term outcomes ...

In top-line results, the phase III trial demonstrated a “highly clinically meaningful reduction” in 24-hour systolic BP.

Juan Granada speaks with Marc Dweck for insights on potential pharmacologic therapies that can impact the progression of ...

Median follow-up duration for patients who survived to discharge after their index admission was 618 days. Over that span, 21 ...

MINNEAPOLIS, MN—Fewer than one-quarter of patients who have heart failure with reduced ejection (HFrEF) and no clinical ...

The exploratory, post hoc look at the trial shows curves starting to separate by month 1, supporting earlier treatment.

Evidence supporting inflammation’s ties to cardiovascular disease is “no longer exploratory but is compelling and clinically ...

Patients had less clinical worsening when treated with this “wonder drug,” as one doctor called it, within a year of ...